Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA -altered head and neck cancer - Hedberg, Matthew L.; Peyser, Noah D.; Bauman, Julie E.; Gooding, William E.; Li, Hua; Bhola, Neil E.; Zhu, Tian Ran; Zeng, Yan; Brand, Toni M.; Kim, Mi-Ok; Jordan, Richard C.K.; VandenBerg, Scott; et al. (The Journal of experimental medicine, 2019)
Keywords: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage; Carcinoma, Squamous Cell - enzymology; Carcinoma, Squamous Cell - genetics; Carcinoma, Squamous Cell - mortality; Carcinoma, Squamous Cell - therapy; Class I Phosphatidylinositol 3-Kinases - genetics; Class I Phosphatidylinositol 3-Kinases - metabolism; Disease-Free Survival; Female; Head and Neck Neoplasms - enzymology; Head and Neck Neoplasms - genetics; Head and Neck Neoplasms - mortality; Head and Neck Neoplasms - therapy; Humans; Male; Mice; Mice, Inbred NOD; Middle Aged; Mutation; Neoplasm Proteins - genetics; Neoplasm Proteins - metabolism; Survival Rate; Xenograft Model Antitumor Assays